Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 10/20 | 0.42 |
| ▸ | CD40 | P25942 | 1/20 | 0.40 |
| ▸ | CD40LG | P29965 | 1/20 | 0.40 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6123787 | 0.96 | ENPP2 (0.41) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL13900472 | 0.96 | ENPP2 (0.41) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL14374615 | 0.94 | ENPP2 (0.40) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL13900499 | 0.93 | ENPP2 (0.38) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL14374585 | 0.92 | ENPP2 (0.45) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL13900494 | 0.92 | CD40 (0.46) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL13852023 | 0.91 | ENPP2 (0.39) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL14268631 | 0.91 | ENPP2 (0.37) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL14268605 | 0.90 | ENPP2 (0.38) | ENPP2CD40CD40LGPHLPP2CYP1A2 | |
| SCHEMBL14374652 | 0.90 | ENPP2 (0.38) | ENPP2CD40CD40LGPHLPP2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8167991-B2 | Trisazo compound, ink composition, recording method, and colored article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | JAK1, TMT1A, CDK1 | ENPP2 4384/4885CD40 4054/4885CD40LG 3920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.